Guangzhou, November 6, 2025 — The highly anticipated “2025–2026 New Nutrition Trends Conference & Nutrition Intelligence Awards Ceremony” was grandly held in Guangzhou. Centered on the theme “Unlocking the Growth Code of the Nutrition Industry: Exploring Future Trends,” the event brought together leading experts, top enterprises, and industry pioneers from across China to decode the concept of “Nutrition Intelligence” and forecast key directions for the year ahead.

One of the conference’s highlights—the 2025 Nutrition Intelligence Awards Ceremony—aimed to honor enterprises and innovations that have made outstanding contributions to the high-quality development of the health and nutrition industry. Among many impressive contenders, Jilin Shengao Biotechnology Co., Ltd. stood out by winning the distinguished “Frontier Technology Exploration Award” for its breakthrough research and innovation in the field of eggshell membrane nutrition and applications.

This prestigious recognition affirms Shengao Biotech’s strong R&D capability and underscores the industry’s growing recognition of the enormous potential of eggshell membrane as a novel, natural bioactive ingredient. In recent years, eggshell membrane has gained global attention for its proven benefits in joint health and overall wellness. With forward-looking vision and dedicated scientific exploration, Shengao Biotech has harnessed advanced biotechnological processes to unlock and enhance the membrane’s active components, transforming this once-overlooked natural material into a “new nutrition” solution with high bioavailability and clear health benefits.

This award represents a milestone in Shengao Biotech’s ongoing pursuit of scientific innovation and translational research in the “New Nutrition” domain. It demonstrates that only through cutting-edge technology and deep exploration of bioactive ingredients can we truly drive the next wave of sustainable growth in the nutrition industry—bringing to market products that deliver genuine value, efficacy, and scientific credibility.

During the conference, Shengao Biotech engaged in in-depth discussions with industry peers on the future of nutrition, innovation pathways, and technology transformation. Looking ahead, Shengao Biotech will take this honor as a new starting point—continuing to uphold its philosophy of “Exploration · Innovation · Intelligent Creation.” The company remains committed to strengthening its R&D investment, advancing the application research of core ingredients such as eggshell membrane, and collaborating with partners across the industry to build a future of health empowered by science and innovation.